Rezolute (RZLT) Preferred Dividend Payments (2016 - 2019)

Rezolute (RZLT) reported Preferred Dividend Payments of $2.2 million for Q1 2019, down 62.24% sequentially from $5.9 million in Q2 2016.

Rezolute (RZLT) Preferred Dividend Payments (2016 - 2019) Analysis & Trends

Rezolute (RZLT) has 2 years of Preferred Dividend Payments data on file, last reported at $2.2 million in Q1 2019.

For the quarter ending Q1 2019, Preferred Dividend Payments changed N/A year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2019 stood at $8.1 million (changed N/A YoY), and the FY2016 full-year result was $6.0 million, changed N/A from the prior year.
Preferred Dividend Payments eased to $2.2 million in Q1 2019, from $5.9 million in the prior quarter.
In the past five years, Preferred Dividend Payments ranged from a high of $5.9 million in Q2 2016 to a low of $61279.0 in Q1 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	-
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Rezolute	518.12 Mn	518.12 Mn	-	-

Download Data